Regenerative Medicine strategy and tissue bioprinting plans announced by 3D Systems

Regenerative Medicine strategy and tissue bioprinting plans announced by 3D Systems

3D Systems, a leading U.S. additive manufacturing company, has announced plans for a Regenerative Tissue Program (RPT). The strategic initiative aims to develop and commercialize bioprinted human tissue, building upon 3D Systems expertise in Healthcare from in-house products such as Virtual Surgical Planning (VSP) and recent acquisitions, including the $400M purchase of Volumetric Biotechnologies.